This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2003 Aug;38(2):527-8.

doi: 10.1002/hep.510380231.

Challenges of designing hepatic encephalopathy treatment trials

Madhusudhan R Sanaka¹, Janus P Ong, Kevin D Mullen

Affiliations

PMID: 12903650
DOI: 10.1002/hep.510380231

Comment

Challenges of designing hepatic encephalopathy treatment trials

Madhusudhan R Sanaka et al. Hepatology. 2003 Aug.

. 2003 Aug;38(2):527-8.

doi: 10.1002/hep.510380231.

Authors

Madhusudhan R Sanaka¹, Janus P Ong, Kevin D Mullen

Affiliation

¹ MetroHealth Medical Center, Cleveland, OH, USA.

PMID: 12903650
DOI: 10.1002/hep.510380231

No abstract available

PubMed Disclaimer

Comment on

Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial.
Mas A, Rodés J, Sunyer L, Rodrigo L, Planas R, Vargas V, Castells L, Rodríguez-Martínez D, Fernández-Rodríguez C, Coll I, Pardo A; Spanish Association for the Study of the Liver Hepatic Encephalopathy Cooperative Group. Mas A, et al. J Hepatol. 2003 Jan;38(1):51-8. doi: 10.1016/s0168-8278(02)00350-1. J Hepatol. 2003. PMID: 12480560 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- The Lens - Patent Citations Database